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Abstract 
Vertebral metastases (VB) remain a real 
challenge in spine surgeons. Recent 
advancements in surgical techniques and 
oncological management allow a more 
aggressive approach of the patient with such 
a pathology, with better results in terms of 
decreasing pain, improvement of the quality 
of life. The aim of this paper is to review 
the optimal surgical planning in metastatic 
spinal tumors. 
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Introduction 
It is well  known that  the liver and lungs 
are the most common distant sites for 
carcinoma. Bone – vertebral column is the 
third site affected (1). The most common 
primary malignancy is prostate cancer for 
men, followed by lung and colon cancer 
(incidence ranging from 160.4 to 65.0 cases 
per 100,0000; for women the first cause for 
vertebral metastases is the breast cancer, 
followed by the same malignancies as in 
men (incidence ranging from 128.9 to 47.0 
cases/ 100,000).  The primary spinal tumors 
are rare as comparing with metastases (2). 
Recent advancement of oncological 
management improved the survival rate of 
patients with malignancies, including the 
ones with vertebral metastases; so spinal 
surgeons are faced very often with such of 
patients and they have to decide which is 
the best way to deal with this kind of 
pathology.  
Vertebral metastases  occur in all age 
groups, with the highest incidence between 
age 40 and 65 years (3). Improvement in 
cancer management leads to increasing 
survival rate, thus to more patients with 
spinal secondary lesions. Cancers of  breast, 
renal, lung, prostate are the most frequent 
primary lesions which will develop spinal 
secondary lesions (4). Classic autopsy 
studies of Willis (5) have demonstrated that 
the size of vertebrae is related with 
secondary lesions. Thus the most affected is 
lumbar region followed by thoracic spine 
and rare cervical spine. Despite this, today 
the studies show that the most affected is 
thoracic spine  (60% to 80%), followed by 
the lumbar spine (15% to 30%), and finally 
the cervical spine (less than 10%)  (6), 
probably related to the smaller size of 
thoracic spinal canal. In transverse plan of 
vertebrae the most affected site is the 
vertebral body (85%), paravertebral spaces 
(10-15%), epidural space (<5%), 
intradural/intramedullary (7). 
Even today we can encounter physicians 
considering the appearance of a spinal 
metastasis to be the death “signature” for 
patients with carcinoma. Advances in 
imaging, early diagnosis, new surgical 
techniques – more aggressive, associated 
with oncological treatment allow to 
improve the management of this patients 
“too sick to be treated”.  
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Treatment 
The three basic treatment modalities in 
vertebral metastasis are chemotherapy, 
radiotherapy and surgery. 
Chemotherapy includes antitumor 
medication, steroids and biphosphonates.It 
is very important to know the sensitivity of 
the tumor to chemotherapy prior to 
treatment.  
Krakoff defines three types of  tumoral 
sensitivity to chemotherapy  (8): 
Higly sensitive 
1. Childhood cancers like acute 
lymphocytic leukemia, 
Wilms tumor, Ewing’s tumor, 
retinoblastoma, and rhabdomyosarcoma. 
2. Hodgkin’s lymphoma. 
3. Carcinoma of the testis. 
4. Choriocarcinoma. 
5. Burkitts tumor. 
6. Acute promyelocytic leukemia. 
In many centers chemotherapy is 
considered the primary treatment for 
patients with these tumors even in the 
presence of epidural compression (9): 
Moderately sensitive 
1. Adenocarcinoma of breast. 
2. Non-Hodgkin’s lymphoma. 
3. Lung cancer. 
4. Osteosarcoma. 
5. Adult myeloid and lymphocytic 
leukemia. 
6. Carcinoma of the prostate. 
7. Colorectal carcinoma. 
8. Female cancers of the ovary, 
endometrium, and cervix. 
Minimally sensitive 
1. Endocrine gland cancers. 
2. Malignant melanoma. 
3. Hepatocellular carcinoma. 
4. Renal carcinoma. 
5. Pancreatic carcinoma. 
Steroids are used for the control of 
biologic pain and vasogenic edema to help 
stabilize neurologic dysfunctions in pre- 
and postoperative periods.   
Biphosphonates tend to inhibit 
osteoclast reabsortion of bone matrix and 
decrease bone turnover. There are three 
generations of biphosphonate currently 
available. 
Radiation Therapy (RT) remained an 
important tool in these patients treatment. 
Since 1970’s RT replaced laminectomy as 
first-line therapy for patients with spinal 
metastasis and cord compression. Recent 
studie (10) have confirmed the utility of RT 
for the treatment of patients with spinal 
metastasis. The standard RT treatment for 
palliation of spinal metastasis is a total dose 
of 3000 Gy; higher doses increases the risk 
for pathologic myelopathy and functional 
spinal cord transection. Today new 
radiation techniques are available: 
intraoperative RT, 3-D conformal RT, and 
intensity-modulated RT. All these 
techniques may permit the delivery of a 
higher dose of radiation to a target tissue 
while maintaining the dose to the spinal 
cord at a much lower level.  
Surgical management 
Surgical treatment of vertebral 
metastases is a real challenge for a spine 
surgeon. There are many strategies 
currently available for this disease, starting 
with observation to aggressive en bloc 
spondilectomy. Furthermore, it is not 
enough to asses the patient only from the 
surgical point of view, it’s mandatory to 
asses the stage of his cancer, needing a 
multidisciplinary team.  Patients with spinal 
metastases are often compromised and at 
higher risk for surgical and medical 
complications after aggressive treatment.  
McLain (11) identifies the steps for a 
successful surgical plan: 
1. Identify and characterize the tumor. 
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2. Classify the tumor as stage and 
extension. 
3. Identify an indication for surgery - 
relative or absolute. 
4. Review the non-operative options. 
5. Review the options for resection and 
reconstruction. 
6. Determine the role of adjuvant 
therapy. 
There is no clear cut indications for 
surgery in vertebral metastases; however, 
there are some circumstances accepted as 
surgical candidates (12), (13): 
1. Unknown or impossibility to establish 
the histological diagnosis 
2. Neurological compression owing to 
pathological fracture with bony 
impingement, vertebral collapse more than 
50% of vertebral height, kyphosis more 
than 50º; 
3. Mechanical instability with severe 
pain or impending neurological injury. 
4. Tumor progression in face of, or 
following radiotherapy. 
5. Known radio-resistant tumor. 
6. Resectable solitary metastasis in 
patient with potential long-term survival. 
There are also some relative 
contraindications: 
1. longstanding complete paralysis (more 
than 24 hrs) 
2. highly radiosensitive tumor 
(lymphoma, myeloma) 
3. multiple levels of involvement 
4. poor life expectancy (less than 3 
months) 
5. extreme medical comorbidities 
An important issue is timing of surgery, 
especially for the patients with neurological 
deficits. Complete paralysis has less chances 
to recovery after 24 hours. However, 
surgery is indicated in patients with partial  
neurological deficits  appeared for 3 days or 
less (14). 
Terminology and Surgical 
Staging/Preoperative Prognostic Score 
It is necessary to establish some 
definitions in order to describe the degree 
of tumoral resection in spine.  The surgery 
of musculoskeletal tumors delineates the 
resection as intralesional, marginal, wide, 
and radical margins. In spine surgery this 
radical margins are very difficult to achieve 
due to presence of neural elements. That’s 
why the applications of the oncological 
staging systems for long bones such as 
Enneking system for the surgical staging of 
bone and soft-tissue tumors is difficult (15). 
There are many surgical staging systems, 
and prognostic systems designed to evaluate 
each patient in order to choose the optimal 
surgical treatment. 
In 1997, Weinstein, Boriani and Biagini 
describe the terms of surgical resection and 
surgical staging system (WBB) (16): 
“Curettage” – piecemeal removal of the 
tumor – intralesional procedure 
“En bloc” – removal of the tumor in one 
piece, alltogether with a layer of healthy 
tissue.  The piece has to be sent to histological 
studies to define “intralesional”, “marginal” or 
“wide” (15) as shown in Figure 1. 
“Radical resection” – en bloc removal of 
the tumor and the whole compartment of 
tumor origin. This is practically impossible 
in spine tumor due to presence of  nervous 
tissue. 
“ Palliation” – surgical procedure with a 
functional purpose – spinal cord 
decompression, fracture stabilisation +/- 
partialor piecemeal resection of the tumor 
leading to control the pain, improvement of 
neurological deficit. 
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Figure 1  Types of surgical resection 
 
 
 
Figure 2 WBB surgical staging for spine tumors - in axial plane the vertebra is divided in 12 radiating zones and 
5 layers (from A to E). ( from WBB Surgical Staging System, 1997) 
 
 
There are 3 methods for performing en 
bloc exicisions depending of tumor’s 
location (16): 
• Vertebrectomy  (marginal/wide en 
bloc excision of the vertebral body) – tumor 
is located in zones 4 to 8 or 5 to 9, and at 
least one pedicle is free from tumor.  
• Sagittal resection (marginal/wide) - 
tumor is located in zones 3 to 5 or 8 to 10, 
which means that it is situated eccentrically 
within the body, pedicle, transverse process. 
• Resection of posterior arch resection 
(marginal/wide)   - tumor is located in 
zones 10 to 3. 
Although WBB system is designed for 
primary spine tumors, it can be successfully 
used for spine metastases. 
In 2001 Tomita discloses his results 
using another scoring system for spinal 
metastases using 3 prognostic factors  (17) 
as shown in Table 1. 
1) grade of malignancy (slow growth - 1 
point; moderate growth - 2 points; rapid 
growth – 4 points),  
2) visceral metastases (no metastasis - 0 
points; treatable - 2 points: untreatable - 4 
points),   
3) bone metastases (solitary or isolated - 
1 point; multiple – 2 points). 
Prognostic score between 2 and 10. 
En bloc resecn 
Intralesional – the cut is within the 
tumor 
 
Marginal – dissection along the 
psudocapsule of tumor 
 
Wide – the cut is outside the 
pseudocapsule, removing the 
tumor with a layer of healthy 
tissue 
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Another scoring system was proposed by 
Tokuhashi (18). It is a preoperative 
prognostic scoring system taking into 
account six variables in order to evaluate life 
expectancy of the patients (table 2). 
Aggressive surgery is reccomended for 
patients having a score of  9 or more and 
palliative surgery for scor of 5 or less. 
Hecht  (19) describes surgical strategies 
according to life expectancy and surgical 
staging using Tomita and Tokuhashi scores. 
(Table 4) 
Table 1   
Tomita preoperative prognostic score 
 
 
Table 2 
Tomita’s local extension of lesion 
 
 
 
Table 3 
Tokuhashi prognostic scoring system 
General status Score Metastases to 
major internal 
organs 
Score 
General condition 
(Karnofsky) 
10-40 
50-70 
80-100 
 
 
0 
1 
2 
Nonremovable 
Removable 
None 
0 
1 
2 
No of extraspinal 
bone metastases 
>3 
2 
 
1 
 
 
0 
1 
 
2 
 
 
Lung, stomach 
Kidney, liver, 
uterus 
Thyroid, prostate, 
breast, rectum 
 
 
0 
1 
 
2 
No of metastases in 
the spine 
>3 
2 
1 
 
 
0 
1 
2 
Neurological 
deficit 
Complete 
Incomplete 
None 
 
 
0 
1 
2 
Tokuhashi score 
0-4 
5-8 
9-12 
 Life expectancy 
<3 months 
<6 months 
>6 months 
 
 
Table 4  
Surgical strategies according to life 
expectancy and Tomita and Tokuhashi scores 
Tokuhashi 
score 
Life 
expectancy 
Tomita 
scoring 
system 
Surgical 
technique 
0-4  <3 months 1-7  Laminectomy 
+fixation  
5-8  3-6 months 1-7  Posterior 
decompression + 
fixation 
+reconstruction  
9-12  >6 months 1-3 
 
 
4-6 
 
 
7  
En bloc resection 
+reconstruction 
360°  
Intralesional 
vertebrectomy+ 
reconstruction 360° 
Posterior 
decompression and 
fixation  
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Discussion 
The management of patients with spinal 
metastases is frequently a challenging task, 
with many risks. In the past the treatment 
was radiation therapy associated or not with 
laminectomy; but laminectomy alone leads 
to secondary aggravation of the neurological 
deficit due to increased spine instability. 
Therefore, more sofisticated techniques 
were developed for this kind of lesions 
including anterior/anterolateral approaches 
combined or not with posterior approaches, 
tumor removal in different ways, associated 
with reconstruction and stabilisation.  
This techniques allowed  a more 
aggressive tactics, improving the survival 
rate and the quality of life. This more 
extensive /aggressive surgical technique 
prolonge significantly the survival rate – 
18,8 month for en bloc resection compared 
with 3,7 month for palliative surgery (4). 
The most important issue in dealing 
with spine metastases is a proper 
assessment. It can be done using surgical 
staging systems and preoperative prognostic 
scores as described above. However, there 
is a lack of standardization of the surgical 
terms sometimes is used the same term for 
different surgical procedures (20). 
Using this instrument it is possible to 
choose the optimal treatment for the patient 
(avoiding overtreatments or 
undertreatments - patient too sick to be 
treated). 
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